Xue Bai Selected Research

Immune Checkpoint Inhibitors

1/2023	Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
1/2023	Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validation.
1/2023	Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
1/2023	CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.
1/2023	Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
9/2021	Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.
1/2021	Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies.
1/2021	Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy.
1/2021	De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.
12/2019	Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue Bai Research Topics

Disease

127	Neoplasms (Cancer) 05/2024 - 08/2005
44	Melanoma (Melanoma, Malignant) 06/2024 - 10/2017
39	Infections 02/2024 - 02/2012
36	Inflammation (Inflammations) 02/2024 - 08/2010
28	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2005
22	Pain (Aches) 04/2024 - 01/2019
19	Lung Neoplasms (Lung Cancer) 11/2023 - 09/2012
18	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2018
16	Hypoxia (Hypoxemia) 01/2023 - 01/2013
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 02/2015
13	Neuralgia (Stump Neuralgia) 04/2024 - 11/2016
13	Ischemic Stroke 04/2024 - 09/2012
12	Disease Progression 04/2024 - 01/2018
11	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 07/2013
11	Hyperalgesia 12/2023 - 11/2016
11	Brain Ischemia (Cerebral Ischemia) 03/2023 - 07/2013
10	Stroke (Strokes) 03/2024 - 01/2013
10	Hypertension (High Blood Pressure) 03/2024 - 01/2013
10	Ischemia 11/2023 - 12/2010
10	Body Weight (Weight, Body) 01/2023 - 03/2009
9	Carcinogenesis 04/2024 - 05/2016
9	Colitis 01/2023 - 01/2019
8	Fibrosis (Cirrhosis) 03/2024 - 08/2010
8	Wounds and Injuries (Trauma) 02/2024 - 08/2021
8	Cognitive Dysfunction 01/2024 - 01/2011
8	Leukemia 01/2024 - 01/2011
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 09/2012
7	Obesity 04/2024 - 06/2015
7	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 10/2016
7	Cardiomegaly (Heart Hypertrophy) 06/2023 - 08/2010
7	Adenocarcinoma of Lung 03/2023 - 01/2021
6	Reperfusion Injury 05/2024 - 09/2012
6	Overweight 04/2024 - 02/2011
6	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 01/2012
6	Altitude Sickness (Mountain Sickness) 11/2023 - 01/2020
6	Trichinellosis 10/2023 - 06/2013
6	Stomach Neoplasms (Stomach Cancer) 09/2023 - 03/2013
6	Nervous System Diseases (Neurological Disorders) 01/2023 - 01/2022
6	Atherosclerosis 01/2022 - 09/2013
5	Liver Cirrhosis (Hepatic Cirrhosis) 05/2024 - 11/2014
5	Triple Negative Breast Neoplasms 04/2024 - 01/2021
5	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2018
5	Hypothyroidism 12/2023 - 02/2011
5	Hearing Loss (Hearing Impairment) 09/2023 - 01/2021
5	COVID-19 08/2023 - 07/2020
5	Virus Diseases (Viral Diseases) 03/2022 - 02/2015
5	Thrombosis (Thrombus) 01/2022 - 12/2017
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 09/2014

Drug/Important Bio-Agent (IBA)

52	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2005
21	MicroRNAs (MicroRNA)IBA 04/2024 - 04/2014
19	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2014
18	AntioxidantsIBA 12/2023 - 09/2012
17	CytokinesIBA 01/2024 - 10/2015
15	EnzymesIBA 12/2023 - 01/2020
14	Messenger RNA (mRNA)IBA 01/2023 - 01/2013
11	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2020
11	Therapeutic UsesIBA 01/2024 - 09/2007
10	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2019
9	Immunoglobulin G (IgG)IBA 12/2023 - 08/2012
9	Transcription Factors (Transcription Factor)IBA 12/2023 - 09/2012
9	Analgesics (Analgesic Drugs)IBA 10/2023 - 01/2015
8	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2023 - 07/2021
8	Heme Oxygenase-1IBA 10/2023 - 07/2021
7	RNA (Ribonucleic Acid)IBA 10/2023 - 11/2019
7	Paclitaxel (Taxol)FDA LinkGeneric 03/2023 - 02/2017
7	salicylhydroxamic acid (SHAM)IBA 04/2016 - 09/2012
6	apatinibIBA 04/2024 - 10/2018
6	AntigensIBA 01/2024 - 07/2014
6	AlbuminsIBA 01/2024 - 10/2019
6	Adenosine Triphosphate (ATP)IBA 11/2023 - 11/2021
6	GYY 4137IBA 05/2023 - 07/2021
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2009
6	Phosphotransferases (Kinase)IBA 01/2023 - 08/2010
6	Peptides (Polypeptides)IBA 12/2022 - 01/2021
6	LipidsIBA 08/2022 - 02/2011
6	Small Interfering RNA (siRNA)IBA 01/2022 - 07/2014
6	Serine Proteases (Serine Protease)IBA 01/2021 - 06/2013
5	Capsules (Microcapsules)IBA 04/2024 - 01/2015
5	LipopolysaccharidesIBA 01/2024 - 02/2020
5	ErbB Receptors (EGF Receptor)IBA 01/2024 - 08/2010
5	NF-kappa B (NF-kB)IBA 12/2023 - 08/2010
5	Ion Channels (Ion Channel)IBA 11/2023 - 12/2022
5	Retinaldehyde (Retinal)IBA 11/2023 - 01/2017
5	Programmed Cell Death 1 ReceptorIBA 08/2023 - 05/2019
5	Circular RNAIBA 06/2023 - 12/2021
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2023 - 07/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2016
5	Oxidoreductases (Dehydrogenase)IBA 12/2022 - 12/2020
5	AntibodiesIBA 10/2022 - 08/2012
5	Long Noncoding RNAIBA 10/2022 - 01/2019
5	diallyl disulfide (diallyl disulphide)IBA 07/2022 - 07/2021
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 04/2017

Therapy/Procedure

106	Therapeutics 06/2024 - 01/2011
33	Drug Therapy (Chemotherapy) 04/2024 - 01/2010
31	Immunotherapy 01/2024 - 04/2015
10	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 03/2009
8	Transplantation 01/2024 - 01/2014
8	Radiotherapy 10/2023 - 10/2019
5	Photochemotherapy (Photodynamic Therapy) 03/2024 - 09/2017
5	Pain Management 01/2023 - 01/2019